Mariângela Ribeiro Resende

Prof. Dr. Mariângela Ribeiro Resende


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Medical Mycology
Verified
Journal Article
Closed access
MMMaria Luiza Moretti
Maria Luiza Moretti
PTPlinio Trabasso
Plinio Trabasso
LLLuzia Lyra
Luzia Lyra
RFRenata Fagnani
Renata Fagnani
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
ASAngélica Zaninelli Schreiber
Angélica Zaninelli Schreiber
From 2006 to 2010, a retrospective study was conducted in a university referral tertiary care hospital to study the frequency and distribution of Candida species in different medical specialties. The use of mechanical ventilation, central venous catheter, and urinary catheter were recorded per 1,000 patient-days and the use of antifungals was calculated using defined daily dose (DDD). A total of 313 episodes were identified and the overall incidence was 0.54 (0.41-0.71) episodes per 1,000 patient-days. Candida albicans caused 44% of the overall episodes, followed by C. tropicalis (21.7%), C. parapsilosis (14.4%), C. glabrata (11.2%), and C. krusei (3.5%). The incidence of C. glabrata significantly increased from 2006-2010 (range: 4.8-23.5%) (P = 0.024). Candida glabrata was associated with malignancies (P = 0.004) and C. krusei with hematologic malignancies (P < 0.0001). The use of antifungals was higher in the hematology/bone marrow transplant units and represented 40% of all fluconazole prescription in the hospital. There was no correlation with the use of fluconazole and the increasing ratio of C. glabrata (r = 0.60). The use of invasive devices was significantly higher in the intensive care units (ICUs) than the medical and surgical emergencies units (P < 0.001). In contrast, the emergencies had higher incidence of candidemia (2-2.1 episodes/1,000 patient-days) than the ICUs (1.6 episodes 1,000 patient-days). Candida glabrata candidemia showed a significant increase in contrast to the current national literature where C. parapsilosis remained the most important non-C. albicans Candida species in Brazilian hospitals. Our findings suggested that the increasing incidence of C. glabrata was not associated with use of fluconazole and other risk factors might play an important role.

31 October 2006 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RARodrigo Angerami
Rodrigo Angerami
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
AFAdriana F.C. Feltrin
Adriana F.C. Feltrin
GKGizelda Katz
Gizelda Katz
ENElvira M. Nascimento
Elvira M. Nascimento
LSLuiz J. Silva
Luiz J. Silva

1 April 2009 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
ADA.C.D. Delgado
A.C.D. Delgado
RPR. de Jesus Pedro
R. de Jesus Pedro
FAF.H. Aoki
F.H. Aoki
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
PTPlinio Trabasso
Plinio Trabasso
MMM.L. Moretti
M.L. Moretti
The objective of this study was to evaluate Candida oral colonization in human immunodeficiency virus (HlV)-infected patients undergoing long-term highly active antiretroviral therapy (ARV). The cross-sectional study included 331 HIV patients, diagnosed from 1983 to 2003. Oral swabs were performed, and Candida species were determined using ID 32C. Isolates were tested for antifungal susceptibility. Clinical and laboratory data were collected to identify the association with Candida colonization. In total, 161 Candida isolates were detected among 147 of the 331 patients (44%), independently of the time when HIV infection was diagnosed. Candida albicans strains represented 137 (85%) of the isolates, and were susceptible to all of the tested antifungal drugs. Among the non-C. albicans strains, six isolates were dose-dependently susceptible to fluconazole, nine to itraconazole, and seven to ketoconazole. The isolation of Candida was significantly higher in patients with virological failure (83/147; p 0.0002) and CD4+ T-lymphocyte counts <200 cells/mm3 (30/83; p 0.0003). Recovery of Candida in the oral cavity was independent of protease inhibitor (PI) usage (p 0.60). Colonized patients typically underwent salvage therapy (p 0.003), and had more episodes of opportunistic fungal infections (p 0.046) and malignancies (p 0.004). Oral Candida colonization in patients under ARV therapy was associated with the immunosupressed status of HIV-infected patients, i.e. low number of CD4+ T-cells per cubic millimetre, failure of ARV therapy (salvage therapy), and higher number of opportunistic infections and malignancies. Despite the fact that Pls have in vitro antifungal activity, the use of this class of antiretroviral agent did not influence the presence of Candida in the oral cavity of AIDS patients.

1 April 2005 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
MGMárcia Teixeira Garcia
Márcia Teixeira Garcia
RFRosely Moralez Figueiredo
Rosely Moralez Figueiredo
MMMaria Luiza Moretti
Maria Luiza Moretti
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
ABAloásio J. Bedoni
Aloásio J. Bedoni
PPPriscila Maria O. Papaiordanou
Priscila Maria O. Papaiordanou
Objective: The objective of this study was to evaluate HIV postexposure prophylaxis (PEP) protocol in rape victims. Study: The victims were assigned to 1 of 3 categories, according to the severity of exposure (I—low, II—moderate, III—high). HIV PEP was provided to victims in groups II (Zdv + 3TC) and III (Zdv + 3TC + PI) until 72 hours after exposure. The follow-up was 6 months. Results: From May 1997 to October 2001, 347 victims were attended. PEP was offered to 278 victims (141 in group II and 137 in group III). Side effects were more common in group III (P <0.01). No seroconversion was diagnosed in the 180 victims that completed the follow-up. Univariate analysis showed that the schooling level, knowledge of the aggressor's HIV status, and the use of PEP were associated with compliance. Conclusions: Triple therapy was associated with side effects, which suggested that drug regimes should be reviewed. The variables related to a high risk of HIV transmission were also significant for compliance.

1 December 2007 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
SBSandra C. Barão
Sandra C. Barão
LSLuiz J. da Silva
Luiz J. da Silva
Vera LF de Camargo-NevesVera LF de Camargo-Neves
Vera LF de Camargo-Neves
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
Many aspects of the human asymptomatic visceral leishmaniasis (VL) remain not elucidated, and moreover, almost all the data come from highly endemic areas. The recent appearance of American VL (AVL) in the northeastern region of the state of São Paulo, Brazil, offered a good opportunity for further understanding. We present the preliminary results from a seroprevalence study on AVL in humans in Araçatuba, São Paulo. This was a cross-sectional survey on a random sample of the population (one-stage simple random sampling) in two areas, using rK39 dipstick tests. The sex ratios and age distributions in the two areas were comparable. Detectable antibodies were found in 23 subjects (20%) in area A1 and in 6 subjects (4.8%) in area A2. There was no significant difference in age distribution of seropositivity between the areas. We observed a difference in asymptomatic infection rates between the two areas, possibly associated with socioeconomic levels and transmission intensity.

31 October 2006 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RARodrigo Angerami
Rodrigo Angerami
MRMariângela Ribeiro Resende
Mariângela Ribeiro Resende
AFAdriana F.C. Feltrin
Adriana F.C. Feltrin
GKGizelda Katz
Gizelda Katz
ENElvira M. Nascimento
Elvira M. Nascimento
LSLuiz J. Silva
Luiz J. Silva